AGM Presentation 21st February 2013 - Optos

More documents

Recommendations

Info

Summary ‣ A positive first quarter - Strong new customer growth driven by Daytona ‣ Significant investment during prior year - Acquisition of new business - New devices including Daytona - Growing the sales channel ‣ Continued good progress entering ophthalmology driven by 200Tx and clinical studies ‣ Ongoing investment in clinical validation with multi site studies underway ‣ Continued opportunity to leverage incremental growth and margins in core business ‣ Key FY13 growth drivers in place – Daytona – 200Tx in ophthalmology – Margin improvement Focus is on execution 14
Achieving Our Vision Measuring Success Financially We want 20:20 vision… 20 20 20% Revenue Growth Per Annum 20% Operating Margin 15
Page 1 and 2: AGM Presentation 21st February 2013
Page 3 and 4: Today’s Agenda 1. Q1 FY13 Highlig
Page 5 and 6: Today’s Agenda 1. Q1 FY13 Highlig
Page 7 and 8: Achieving Our Vision ‘Filling the
Page 9 and 10: Achieving Our Vision Globalising UW
Page 11 and 12: Achieving Our Vision Demonstrating
Page 13: Today’s Agenda 1. Q1 FY13 Highlig
Page 17: Q Business & A Model 17

AGM Presentation 21st February 2013 - Optos

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?